Doximity (DOCS)Director sold ~$75K

~$75K

Approx. value · 2,000 sh @ $37.33

20K

Holds after · shares reported

Traded

Feb 2, 2026

Filed

Feb 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 6, 2025CongressDisclosed sale of DOCS — reported range $15,001 - $50,000
2. Dec 1, 2025InsiderDirector sold ~$101K of DOCS shares in the open market
3. Jan 2, 2026InsiderDirector sold ~$89K of DOCS shares in the open market
4. Feb 2, 2026 · this disclosureInsiderDirector sold ~$75K of DOCS shares in the open market

What came next

1. Feb 3, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On February 5, 2026, Doximity, Inc. (“Doximity” or the “Company”) announced that Anna Bryson, the Company’s Chief Financial Officer, principal financial officer, and principal accounting officer, is taking a temporary medical leave of absence.”
2. Feb 10, 2026InsiderOfficer sold ~$64K of DOCS shares in the open market
3. Mar 3, 2026InsiderDirector sold ~$52K of DOCS shares in the open market
4. Mar 10, 2026InsiderOfficer sold ~$59K of DOCS shares in the open market
5. Apr 10, 2026InsiderOfficer sold ~$51K of DOCS shares in the open market
6. Apr 13, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 13, 2026, the Company accepted her resignation as Chief Financial Officer. Effective February 3, 2026, the Company’s Board of Directors appointed Siddharth Sitaram, the Company’s Chief Accounting Officer, to serve as the Company’s interim principal financial officer and interim principal accounting officer.”
7. May 7, 2026InsiderDirector sold ~$235K of DOCS shares in the open market
8. May 11, 2026InsiderOfficer sold ~$60K of DOCS shares in the open market
9. May 13, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On May 13, 2026, Doximity, Inc. (the “Company”) announced the appointment of Matthew Sonefeldt as Chief Financial Officer of the Company, effective May 13, 2026.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Doximity

For Doximity, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DOCS page.

Other recent filings by Kira Scherer Wampler, Director

• SEC Form 4 at Doximity (DOCS)Oct 6, 2026
• SEC Form 4 at Doximity (DOCS)Sep 4, 2026
• SEC Form 4 at Doximity (DOCS)Aug 28, 2026
• SEC Form 4 at Doximity (DOCS)May 9, 2026
• SEC Form 4 at Doximity (DOCS)Mar 6, 2026

The full history of Kira Scherer Wampler, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Doximity

• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 3, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 4Sep 4, 2026
• SEC Form 4Aug 28, 2026
• SEC Form 4Aug 18, 2026

Everything OQRO holds on this company is on its DOCS page.